Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil

BACKGROUND: We assessed long-term metabolic and endocrine profiles of outpatients with schizophrenia participating in a one-year open-label extension study of monthly aripiprazole lauroxil (AL), a long-acting injectable antipsychotic. METHODS: Patients (N = 478) were enrolled in a 52-week, open-labe...

全面介紹

Na minha lista:
書目詳細資料
發表在:Psychopharmacol Bull
Main Authors: Nasrallah, Henry A., Aquila, Ralph, Stanford, Arielle D., Jamal, Hasan H., Weiden, Peter J., Risinger, Robert
格式: Artigo
語言:Inglês
出版: MedWorks Media Global 2017
主題:
Original Presentations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546549/
https://ncbi.nlm.nih.gov/pubmed/28839338
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍